Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Nature Medicine|April 26, 2024
Bispecific T cell engager therapy for refractory rheumatoid arthritisLaura Bucci, Melanie Hagen, Tobias Rothe, et al.
Rheumatology (Oxford, England)|July 21, 2022
Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitisFederica Bello, Alessandra Bettiol, Elena Silvestri, et al.
Annals of the Rheumatic Diseases|May 7, 2021
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseasesDavid Simon, Koray Tascilar, Filippo Fagni, et al.
Biomedicines|June 24, 2022
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA)Elena Niccolai, Alessandra Bettiol, Simone Baldi, et al.
Scientific Reports|April 20, 2025
Serum extracellular matrix biomarkers in rheumatoid arthritis, psoriatic arthritis and psoriasis and their association with hand functionHelena Port, Birte Coppers, Sonja Tragl, et al.
International Journal of Molecular Sciences|May 27, 2023
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet's Syndrome and Psoriatic ArthritisAlessandra Bettiol, Filippo Fagni, Irene Mattioli, et al.
Rheumatology (Oxford, England)|July 2, 2026
Cardiac involvement in Behçet's syndrome: findings from a clinically driven cardiological evaluationAlessandra Bettiol, Federica Bello, Ruggero Mazzotta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 24, 2021
Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated CohortDavid Simon, Koray Tascilar, Arnd Kleyer, et al.
Annals of the Rheumatic Diseases|July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Markus Eckstein, Laura Bucci, et al.
Pageof 7